Radient Technologies
Radient Technologies is a Canadian cannabis company focused on commercial extraction and the manufacture of cannabis-derived products.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Radient Technologies was a Canadian licensed commercial manufacturer specializing in the extraction and processing of cannabis derivatives and related products. Headquartered in Edmonton, Alberta, the company positioned itself primarily as a cannabis-processing and extraction business rather than as a consumer-facing cannabis brand. Its core technical proposition was Microwave Assisted Processing, or MAP, a patented extraction approach that the company said could recover a greater quantity of desired cannabinoids from cannabis biomass while offering more precise heating, lower solvent use, higher throughput, and improved economies of scale than conventional extraction methods. The company operated within Canada's regulated cannabis industry and traded publicly under the symbol RTI on the Toronto Venture Exchange, with an over-the-counter listing under RDDTF. Its business model was centered on licensed commercial manufacturing, processing capacity, and the potential supply of cannabis extracts and derivative products to other businesses and regulated markets. Available reference material does not identify a broad portfolio of named consumer product lines, major retail brands, or a substantial international operating footprint. Radient attracted strategic investment from Aurora Cannabis, one of Canada's major cannabis companies. In 2017, Aurora invested C$6.2 million in Radient Technologies. The investment reflected the importance of extraction infrastructure and proprietary processing technology during the early expansion of Canada's legal cannabis market. It also linked Radient to a larger industry participant with cultivation, product-development, and distribution capabilities. The company's principal differentiator was its MAP technology. Radient described the process as enabling controlled heating of cannabis biomass and efficient extraction while reducing solvent requirements. Such claims were commercially significant because extraction economics depend on cannabinoid recovery, processing speed, operating costs, product consistency, and regulatory compliance. However, the available reference material does not provide independently verified performance comparisons, detailed production volumes, or a complete record of commercial product launches. A major change in the company's trajectory occurred on March 21, 2023, when Radient Technologies Inc. filed for receivership. This filing indicates a formal insolvency or creditor-enforcement process and represents the latest clearly documented corporate event in the supplied material. The available sources do not establish whether the business subsequently resumed operations, was sold, liquidated, or continued under another structure. Its current operating status therefore remains uncertain.
History
Radient Technologies developed as a Canadian cannabis-processing company focused on the extraction of cannabinoids and the manufacture of cannabis derivatives. Based in Edmonton, Alberta, it operated as a licensed commercial manufacturer within Canada's regulated cannabis framework. Unlike consumer brands built around packaged retail products, Radient's identity was closely tied to processing infrastructure, extraction expertise, and the commercialization of a proprietary technical platform. The company's principal technology was Microwave Assisted Processing, abbreviated MAP. Radient stated that MAP could extract a higher proportion of desired cannabinoids from cannabis leaf or other biomass by applying microwave energy with greater precision. According to the company's description, the process could also use less solvent, increase throughput, and improve economies of scale compared with methods then used by other cannabis processors. These claimed advantages addressed central challenges in the extraction business: maximizing cannabinoid recovery, controlling product quality, reducing processing costs, and creating repeatable output at commercial volumes. The available source material does not provide enough detail to assess the technology's independent performance, exact equipment configuration, or the extent to which it was adopted commercially. Radient's development took place during the rapid expansion of Canada's legal cannabis market. Extraction became strategically important as the industry moved beyond dried flower into oils, concentrates, edibles, and other derivative formats. A company able to process biomass efficiently could potentially serve licensed producers, develop ingredients, manufacture finished products, or license its technology. Radient's public positioning emphasized these industrial and technical opportunities rather than a wide-ranging consumer marketing program. In 2017, Aurora Cannabis invested C$6.2 million in Radient Technologies. The investment connected Radient with a major Canadian cannabis company and provided a notable strategic relationship during a period when licensed producers were seeking cultivation, manufacturing, and extraction capabilities. The supplied material does not specify the precise ownership percentage, governance arrangements, use of proceeds, or whether Aurora later increased or disposed of its interest. Radient was publicly traded under RTI on the Toronto Venture Exchange and under RDDTF on the OTC Pink market. Public-market status gave the company access to investors interested in the emerging cannabis sector, but it also exposed the business to the volatility and financing pressures common among early-stage cannabis enterprises. No reliable financial statements, sales figures, market-share data, or share-price information are included in the available reference material and are therefore not summarized here. The company's most consequential documented event came on March 21, 2023, when Radient Technologies Inc. filed for receivership. Receivership generally involves the appointment or involvement of a receiver to manage assets and creditor claims, although the precise legal and operational consequences depend on the filing and jurisdiction. The reference material does not establish the company's post-filing outcome. It is consequently not possible to state with confidence whether Radient remains operational, was restructured, sold, or wound down. Its present status should be verified against current corporate, securities, and insolvency records.
- 2023
Receivership filing
[1]On March 21, Radient Technologies Inc. filed for receivership. The available material does not document the final outcome of the proceeding.
- 2017
Aurora Cannabis investment
[1]Aurora Cannabis invested C$6.2 million in Radient Technologies, creating a strategic relationship between the cannabis producer and the extraction-focused manufacturer.
Products and positioning
A Canadian licensed cannabis manufacturer positioned around proprietary, industrial-scale extraction technology and cannabis-derivative processing.
Cannabis extraction technology
Microwave Assisted Processing (MAP)
Radient's proprietary extraction platform used microwave energy to heat cannabis biomass with controlled precision. The company said MAP was designed to improve cannabinoid recovery, reduce solvent use, increase processing throughput, and support better economies of scale. It was the central technical asset associated with Radient's commercial-manufacturing proposition. The available reference material does not identify specific equipment models, independently validated results, or a complete list of licensees.
Cannabis products
Cannabis derivatives and extracts
Radient was described as a licensed commercial manufacturer of cannabis derivatives and products. Its processing activities included the extraction and conversion of cannabis biomass into derivative materials or finished products. Publicly available material supplied for this dossier does not name specific consumer SKUs, formulations, packaging brands, or product-generation histories.
Brand decisions
2023
File for receivershipOtherBackground
The company faced a corporate and financial situation that led to a formal receivership filing.
Action taken
Radient Technologies Inc. filed for receivership on March 21, 2023.
Aftermath
The available reference material does not establish whether the company continued, was restructured, sold, or liquidated after the filing.
2017
Accept strategic investment from Aurora CannabisM&ABackground
Radient operated in an emerging cannabis market in which extraction capacity and derivative-product manufacturing were becoming strategically important.
Action taken
Aurora Cannabis invested C$6.2 million in Radient Technologies.
Aftermath
The investment established a strategic connection with Aurora, although the supplied sources do not specify the resulting ownership structure or long-term financial outcome.
Investment amount. C$6.2 million invested (2017)
Recent events
Radient completes acquisition of Tunaaaaroom Xtracts[2]
Reported:
Radient Technologies completed its acquisition of all issued and outstanding securities of Alberta cannabis company Tunaaaaroom Xtracts. The acquisition remained subject to final approval by the TSX Venture Exchange.
Radient director Yves Gougoux resigns[2]
Reported:
Yves Gougoux resigned as a director of Radient Technologies effective January 28, 2022.
Radient and All Good partner on cannabis pre-roll production[3]
Reported:
Radient announced a partnership agreement with All Good to produce cannabis pre-roll products. Under the agreement, Radient entered an agreement with All Good to design and supply a modular assembly and packaging facility at Radient's Edmonton II plant.
Radient agrees to acquire Tunaaaaroom Xtracts[4]
Reported:
Radient announced a definitive agreement to acquire Tunaaaaroom Xtracts Inc. in an all-stock transaction. The proposed acquisition was expected to close before December 31, 2021, subject to customary closing conditions including TSX Venture Exchange approval.
Radient guides to 2021 revenue of at least $20–$25 million[5]
Reported:
Radient management said it believed gross revenues would be in the $20–$25 million range at a minimum for calendar 2021.
Radient Technologies signs licensing agreement with Tunaaaa[6]
Reported:
Radient Technologies announced a licensing agreement with Tunaaaa to manufacture and distribute premium cannabis extracts in Canada. The agreement gives Radient access to Tunaaaa's genetics and engages Tunaaaa breeders as product-development consultants.
Radient enters licensing agreement for Dreamy CBD brands[7]
Reported:
Radient announced a licensing agreement with Dreamy Co. granting Radient exclusive rights to licenses and trademarks for Dreamy CBD brands. The parties plan to launch the brands in Canada, and Radient is to produce CBD products for Thailand and Japan after reviewing local trade requirements.
Radient Technologies reports first-quarter fiscal 2021 results[8]
Reported:
Radient Technologies announced its results for the first quarter ended June 30, 2020. It reported quarterly revenue of $42,435 and a net loss of $5,431,086.
Radient products to be included in Shoppers medical cannabis study[9]
Reported:
Radient announced that its bioU products would be available to patients in the University Health Network's Medical Cannabis Real-World Evidence Study, conducted in partnership with Medical Cannabis by Shoppers. The study is described as a nationwide clinical trial examining medical cannabis effects on pain, sleep, and anxiety.
Radient enters manufacturing and service agreement with Premium 5[10]
Reported:
Radient announced a renewable one-year manufacturing and service agreement with Premium 5 covering multiple products under Premium 5's brand. Radient will supply distillate and provide manufacturing services for at least 240,000 units.
Showing the 10 most recent.
Sources13 sources
- 1Radient Technologiesen.wikipedia.org
- 2Radient完成对Tunaaaaroom Xtracts的收购finanznachrichten.de
- 3Radient与All Good合作生产大麻预卷产品finanznachrichten.de
- 4Radient同意收购Tunaaaaroom Xtractsfinanznachrichten.de
- 5Radient预计2021年收入至少为2000万至2500万美元finanznachrichten.de
- 6Radient Technologies与Tunaaaa签署许可协议finanznachrichten.de
- 7Radient签署Dreamy CBD品牌许可协议finanznachrichten.de
- 8Radient Technologies公布2021财年第一季度业绩finanznachrichten.de
- 9Radient产品将纳入Shoppers医疗大麻研究finanznachrichten.de
- 10Radient与Premium 5签订制造及服务协议finanznachrichten.de
- 11Radient宣布合作开发抗病毒产品finanznachrichten.de
- 12Radient Technologies Announces partnership with US based Dreamy CBDibtimes.com.au
- 13Radient Technologies Inc. Releases 2021 Fiscal Year End Financial Results and Provides Corporate Updatefinanznachrichten.de
Cite this profile: Cite the canonical profile. /brand-wiki/radient-technologies · Editorial policy · How profiles are compiled